Skip to search formSkip to main contentSkip to account menu

6059-S

Known as: 6059 S, S-6059, 6059S 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Disodium LatamoxefMoxalactam

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1981
1981
[Laboratory and clinical studies on 6059-S in children (author's transl)].
Laboratory and clinical studies were performed on 6059-S in the field of pediatrics, a new semi-synthetic 1-oxacephem antibiotic… 
1981
1981
[Basic and clinical examinations of 6059-S in pediatrics (author's transl)].
1. MIC of 6059-S against 92 strains of clinically isolated bacteria were measured. The compound was active against most of Gram… 
1981
1981
[Experimental and clinical studies on 6059-S (author's transl)].
Experimental and clinical studies in the pediatric field on 6059-S, a newly synthesized broad spectrum parenteral antibiotics… 
1981
1981
High-performance liquid chromatographic analysis of a new beta-lactam antibiotic, 6059-S (moxalactam).
1981
1981
Effect of 6059-S, a novel oxacephem, on cross-linking reaction of peptidoglycan biosynthesis in Escherichia coli, Pseudomonas aeruginosa and Serratia marcescens
The effect of 6059-S, a novel 1-oxacephem, on peptidoglycan synthesis was investigated using ether-treated cells of Escherichia… 
1981
1981
[Clinical results and pharmacokinetics of 6059-S in the field of pediatrics (author's transl)].
6059-S, a new injectable oxacephem antibiotic, has been investigated to give following results. 1. Clinical results Twenty… 
1981
1981
[Clinical studies on 6059-S for acute peritonitis. Clinical effect and tissue concentration (author's transl)].
A new antibiotic drug of oxacephem, with marked resistance to beta-lactamase, 6059-S for parenteral use was tested in 10 patients… 
1981
1981
[Clinical studies on 6059-S for biliary tract diseases. Clinical effect and tissue concentration (author's transl)].
A new antibiotic drug of oxacephem, with marked resistance to beta-lactamase, 6059-S for parenteral use was used in 12 patients… 
1980
1980
Moxalactam (6059-S), a new 1-oxa-beta-lactam: binding affinity for penicillin-binding proteins of Escherichia coli K-12
Moxalactam (6059-S) is a new beta-lactam derivative with a structure markedly different from those of penicillins or… 
1980
1980
The in vitro antibacterial activity of LY127935 (6059S), a novel 1-oxa-beta-lactam antibiotic.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)